Australia's tertiary science and ICT students are being disadvantaged by a lack of industry experience to help them prepare for the workplace after graduating, according to a paper released by the Office of the Chief Scientist. [ + ]

QIMR Berghofer Medical Research Institute and Bristol-Myers Squibb have signed a research collaboration and licence agreement to discover novel therapeutic antibodies against an undisclosed immuno-oncology target. [ + ]

Living Cell Technologies will receive a Callaghan Innovation R&D Growth Grant totalling an estimated NZ$2 million, which will reimburse the company for 20% of eligible New Zealand research and development expenditure over the next three years. [ + ]

CSIRO's Digital Productivity flagship is set to merge with NICTA, creating what has been described as one of the largest digital innovation teams in the world. [ + ]

Imugene has appointed Leslie Chong as its new chief operating officer as of mid-September — a move which saw the company's share price rise by 25% on Thursday. [ + ]

Digital health company Adherium has listed on the Australian Securities Exchange for the first time, opening yesterday at $0.55 per share. [ + ]

Experts in health ethics, policy, patient care and innovation are among those who have been appointed to the National Health and Medical Research Council's five committees. [ + ]

CSIRO is leading an international collaboration of researchers, beekeepers, farmers, industry and technology companies that aims to better understand what is harming the health and pollination ability of honey bees.

Law firm DibbsBarker has announced the appointment of Andrew Rankine as a new special counsel in the company's Sydney office. [ + ]

Terem Technologies has conducted what it claims is the first study into the growth of female technology entrepreneurs, with surprising results. [ + ]

Thanks to a computer program developed at Edith Cowan University, plant classification could become as simple as taking a photo. [ + ]

Specialised Therapeutics Australia has formed an exclusive licence and commercialisation agreement with PharmaMar to market and distribute the oncology drug APLIDIN (plitidepsin) in Australia and New Zealand. [ + ]

Clarity Pharmaceuticals and the University of Melbourne have been awarded an ARC Linkage grant to fund the development of new agents for diagnostic imaging using PET. The ultimate aim of the project is to try to improve molecular imaging of the brain for various disorders. [ + ]

Three Australian research teams will contribute to a global effort to combat the growing incidence of type 2 diabetes, having received NHMRC funding as part of a multicountry grant call through the Global Alliance for Chronic Diseases. [ + ]

Professor Allan Pacey has released an inside look at the process of conception in the human body, framing it as an amazing race between 250 million competitors. [ + ]